Could This Label Expansion Be a Growth Catalyst for Sanofi Stock?
Sanofi and Regeneron's mega-blockbuster drug could soon be approved in the U.S. for yet another indication.
Sanofi and Regeneron's mega-blockbuster drug could soon be approved in the U.S. for yet another indication.